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Abstract Actinomyces neuii, a species first described in
1994, has proven to be an exception in this genus on account
of its aerobic growth, microscopic morphology (no branch-
ing), and the types and location of infections. Abscesses and
infected atheromas are the most frequent types of infections,
followed by infected skin structures, endophthalmitis, and
bacteremias, including endocarditis. They are most likely of
endogenous origin. To date, approximately 100 cases have
been recorded in the literature. Intra-abdominal and intra-
thoracic infections, however, have not yet been described,
and cases of classical actinomycosis seem to be extremely
rare. Prognosis has generally been good with antibiotic and/
or surgical treatment. Susceptibility to antibiotics has par-
alleled that of other Actinomyces spp.
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History and taxonomy
Actinomyces spp. are often thought to be the cause of
actinomycosis, but they are neither the sole agents of the
disease [1] nor do they cause actinomycosis only [2]. In
fact, one of the newcomers in this genus, Actinomyces
neuii, which will be reviewed here, may not cause classical
actinomycosis at all. In 1985, Coudron et al. [3] published
the characteristics of two aerobically growing coryneform
Gram-positive rods isolated from patients with endoph-
thalmitis that resembled organisms earlier called ‘‘Coryn-
eform Group A-4’’ by the Special Bacteriology Reference
Laboratory at the Centers for Disease Control (CDC) [4]
but differed from this group in several biochemical reac-
tions. Coudron et al. called these and five similar reference
strains from the CDC ‘‘A-4-like’’. Two years later, Na’was
and CDC researchers [5] published the characteristics of
several additional ‘‘A-4-like’’ strains, this time under the
term ‘‘CDC Fermentative Coryneform Group 1’’.
In the course of a study aimed at identifying Gram-
positive rods isolated in the author’s laboratory, more such
strains were found and investigated using biochemical and
chemotaxonomic [6] as well as molecular biological [7]
techniques. The results indicated that the Coryneform
Group 1 strains did not belong to any of the hitherto known
genera of aerobically growing Gram-positive rods but were
close to the genera Actinomyces and Arcanobacterium,
which are known to grow better under anaerobic or capn-
ophilic conditions than under aerobic ones. 16S rRNA
sequence analysis and DNA–DNA hybridization studies as
well as cellular and metabolic fatty acid profiles placed
these strains as a species in the genus Actinomyces [6, 7],
which we named Actinomyces neuii [7] after our colleague
Harold Neu, the head of Infectious Disease at Columbia
University who had died in 1993. Two subspecies, A. neuii
subsp. neuii and A. neuii subsp. anitratus, could be dis-
tinguished by biochemical tests [7]. In analogy to the
sequestration of the genera Arcanobacterium and Actino-
baculum from the genus Actinomyces, suggestions have
even been made to create a new genus for A. neuii since it
has turned out to be closer in sequence similarity [8] and
chemotaxonomy [9] to the genera Varibaculum and
Mobiluncus than to A. bovis, the type species of Actinomyces.
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We were surprised that within a 4.5-year period, we
were able to detect 67 strains of A. neuii in our routine
diagnostic laboratory [10] even using an identification
system which is now obsolete [11]. In our as well as
in Clarridge’s [12] laboratory A. neuii was more fre-
quently isolated than A. odontolyticus, A. israelii, A.meyeri,
A. viscosus, and A. naeslundii. At the time this article was
being written, a total of 22 reports of A. neuii infections cov-
ering approximately 100 cases have been published (some
isolates have been listed repeatedly in several publications).
These findings required a change in the concept of
Actinomyces as anaerobic or at best aerotolerant organisms,
in their role as causative agents of diseases other than
classical actinomycosis, and in the frequency of its species
isolated in clinical laboratories. As will be also be shown,
A. neuii has a microscopic morphology that is unusual for
Actinomyces spp, and as an infectious agent it seems to
prefer special areas of the human body.
Isolation and identification
In direct Gram stained preparations and smears from cul-
tures, A. neuii appears as a diphtheroidal and even coccoid
organism without branching [5, 13–15]. Only one case has
been described in which A. neuii (not subspeciated) was
found as an agent of classical actinomycosis with charac-
teristic Gram-positive filaments and sulfur granules [16].
The diagnosis was based 16S rRNA sequencing but the
catalase reaction was negative, a rare trait [13]. Another
report mentioned the presence of multinucleated giant cells
[17]; however, in the remaining cases only polymorpho-
nuclear leukocytes were found. The sensitivity of direct
Gram stains is only approximately 20% [10]. Biochemical
characteristics, among them the positive CAMP reaction,
and the identification of A. neuii by traditional, semiauto-
matic ,and molecular techniques have been subjects of
several publications [12, 14, 18] and will not be discussed
here.
A. neuii grows within 48 h on aerobically and anaero-
bically incubated blood agar plates; very few reports
mention poorer [19, 20] or better [21] growth under
anaerobic conditions. Colonies are indistinguishable from
those of other Actinomyces spp., although most resemble
the smooth variety of other Actinomyces spp.
Habitat and transmission
Several Actinomyces spp. are known as colonizers of the
human body [22] but to date only one study has shown that
A. neuii can be part of the normal flora: DNA–DNA
hybridization showed that it was present in larger numbers
in patients with gingivitis than in orally healthy individuals
[23]. No studies have investigated the presence of A. neuii
in the environment, but based on the types of infections it
must be assumed that it is endogenous. Transmission from
patient to patient has also not been observed, with the
exception of a case of maternal chorioamnionitis in which
A. neuii caused neonatal septicemia (see below).
Infections
Abscesses and infected atheromas Abscesses and infec-
ted atheromas have been, overall, the most frequent
infections from which A. neuii has been cultured [10, 12,
13, 15, 17]. Abscesses were mostly localized in the mam-
mary, axillar, and inguinal areas, similar to other Actino-
myces spp. [22]. In a minority of abscesses and atheromas,
A. neuii was found in pure culture, with the majority
yielding a mixed anaerobic, occasionally also aerobic flora.
These mixtures are also not unusual in similar Actinomyces
spp. infections [24]. In our own cases, community acqui-
sition was the rule, immunosuppression was rare, and
treatment with systemic antimicrobials alone yielded poor
results or relapses. The outcome was satisfactory if the
infected focus was removed by surgery [10].
Infected skin lesions Infected skin lesions, such as com-
munity-acquired diabetic ulcers, were second in frequency
in our own collection [10] but have been published else-
where in single cases only [5, 21]. Mixtures with coagu-
lase-negative staphylococci were the rule.
Endophthalmitis Endophthalmitis following phacoemul-
sification and lens implantation has been reported in three
publications [25–27], although more isolates of A. neuii
from eyes have been recorded without details [5, 8].
Intraocular, topical, and systemic application of antibiotics
led to successful outcomes in two cases [26, 27], while one
patient developed a central vein occlusion [25]. Endoph-
thalmitis due to other Actinomyces spp. has been known for
some time [28].
Endocarditis Endocarditis has been reported in two
patients, one on a prosthetic valve [19] and one compli-
cated by an aortic abscess [29]. The former was cured by
antibiotic treatment (penicillin) alone, while the second one
required combined medical (ampicillin)–surgical treat-
ment. Other Actinomyces spp. have been known as agents
of endocarditis as well [30].
Bacteremia Blood cultures positive for A. neuii as the
only organism have been reported in 12 patients [5, 10, 14,
31, 32], excluding those with endocarditis (the Abstract of
reference [19] erroneously lists 14 patients with endocar-
ditis). Of the bacteremias whose histories were detailed,
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two originated from the urinary tract [14], one was septi-
cemia in a newborn that had its origin in a maternal cho-
rioamnionitis [31], and one originated from either a urinary
tract or a joint infection [10]. All of these were healthcare-
associated. With the exception of the latter case, antibiotic
treatment was successful. Bacteremias with other Actino-
myces spp. have recently been published [33].
Other infections Single cases of pericarditis [34], oste-
omyelitis (with a mixed culture; [35]), and chorioamnio-
nitis [31] as well as infections of a periprosthetic joint [36],
a ventriculo-peritoneal shunt [20], and a penile prosthesis
reservoir [37] have been published. We have also observed
cases of urinary tract infection and of prostatitis [10].
Similar infections have been caused by other Actinomyces
spp. [1, 12, 14, 22, 24]. Removal of prosthetic devices and
antibiotics led to successful outcomes.
Of note, no isolates of A. neuii have been reported from
intra-abdominal and -thoracic sources, which figure promi-
nently in other Actinomyces spp. infections [1, 24]. Of
those isolates that were subspeciated, subsp. neuii pre-
vailed over subsp. anitratus. There was no preference for
age or sex; and immunocompromised individuals were
more frequent only among those with systemic disease and
skin lesions. Potential virulence factors have not been
investigated thus far.
Antimicrobial susceptibility
The antimicrobial susceptibility of A. neuii corresponds to
that of other Actinomyces spp. [38]. To date, all strains
have been susceptible to penicillin, ampicillin, the cepha-
losporins, imipenem, rifampicin, vancomycin, erythromy-
cin, and clindamycin [3, 10, 13, 19–21, 25, 27, 29, 31, 35,
36]. A few were resistant to tetracycline [6, 10]. Suscep-
tibility to aminoglycosides and ciprofloxacin has varied
[10, 15, 21, 25, 27, 29]. For treatment, beta-lactam anti-
biotics and vancomycin have been preferentially used.
Development of resistance to the above listed antibiotics
has not been observed so far.
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